ArticlePEC innovation2023

Development of a novel measure of advanced cancer patients' perceived utility of secondary germline findings from tumor genomic profiling.

Jada G Hamilton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.